Published: Friday, May 17, 2024 · 6:15 PM | Updated: Friday, May 17, 2024 · 6:15 PM
📊 558 views
May 16, 2024 / 01:00PM GMT
Operator
Good afternoon, and welcome to the Celadon Pharmaceuticals Plc full year results investor presentation. (Operator instructions) Before we begin, I would like to submit the following pole and I would now like to hand over to CEO, James Short. Good afternoon to you.
James Short – Celadon Pharmaceuticals Plc – co-founder & CEO
Good afternoon, thank you. Thank you, everybody, for joining us today. Some new ones and some rooms that have been supportive over the years. Hopefully, at the end of this presentation, we can make a lot more clearer of the success that we’ve had through the past five years. I’m also joined by Jonathan Turner, our CFO, who will go through a number of the slides.
What I’d like to do is I always tend to start with this slide and how and the idea is that we tried to reiterate the Celadon is a pharmaceutical company, the operates using cannabinoids, it is not a cannabis company and there are completely fundamental differences of our set the business up. The cannabis adult recreational market is one market, but we are in the
MORE IN INSIDE INVESTMENT NEWS
AI Funding Fears Rattle Wall Street: Adjusting for Alpha and Preservation
Published: Saturday, October 24, 2026 · 12:28 PM
Volvo Cars Plunge: Alpha Warning as China Sales Slump Hits Earnings
Published: Friday, October 23, 2026 · 6:18 AM
